ARTICLE
29 July 2019

Development Of Substituted Pyrido[3,2-D]Pyrimidines As Potent And Selective Dihydrofolate Reductase Inhibitors For Pneumocystis Pneumonia Infection

KL
Herbert Smith Freehills Kramer LLP

Contributor

Herbert Smith Freehills Kramer is a world-leading global law firm, where our ambition is to help you achieve your goals. Exceptional client service and the pursuit of excellence are at our core. We invest in and care about our client relationships, which is why so many are longstanding. We enjoy breaking new ground, as we have for over 170 years. As a fully integrated transatlantic and transpacific firm, we are where you need us to be. Our footprint is extensive and committed across the world’s largest markets, key financial centres and major growth hubs. At our best tackling complexity and navigating change, we work alongside you on demanding litigation, exacting regulatory work and complex public and private market transactions. We are recognised as leading in these areas. We are immersed in the sectors and challenges that impact you. We are recognised as standing apart in energy, infrastructure and resources. And we’re focused on areas of growth that affect every business across the world.
Intellectual Property scientific advisor Khushbu Shah co-authored an article titled "Development of Substituted Pyrido[3,2-d]Pyrimidines as Potent and Selective Dihydrofolate Reductase
United States Food, Drugs, Healthcare, Life Sciences

Intellectual Property scientific advisor Khushbu Shah co-authored an article titled "Development of Substituted Pyrido[3,2-d]Pyrimidines as Potent and Selective Dihydrofolate Reductase Inhibitors for Pneumocystis Pneumonia Infection" which was published in ScienceDirect on June 4, 2019. The article discusses efforts to develop novel compounds that can provide safer treatment for pneumocystis pneumonia infection.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More